BIOMAT Database Logo BIOMAT Database Logo

Identification of epitopes for CTCL-specific cytotoxic T lymphocytes. 1998

T Linnemann, and C Brock, and K Sparbier, and M Muche, and A Mielke, and A Lukowsky, and W Sterry, and K Kaltoft, and K H Wiesmüller, and P Walden
Department of Dermatology, Medical Faculty Charité, Humboldt University, Berlin, Germany.

UI MeSH Term Description Entries
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D002999 Clone Cells A group of genetically identical cells all descended from a single common ancestral cell by mitosis in eukaryotes or by binary fission in prokaryotes. Clone cells also include populations of recombinant DNA molecules all carrying the same inserted sequence. (From King & Stansfield, Dictionary of Genetics, 4th ed) Clones,Cell, Clone,Cells, Clone,Clone,Clone Cell
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic
D012878 Skin Neoplasms Tumors or cancer of the SKIN. Cancer of Skin,Skin Cancer,Cancer of the Skin,Neoplasms, Skin,Cancer, Skin,Cancers, Skin,Neoplasm, Skin,Skin Cancers,Skin Neoplasm
D013602 T-Lymphocytes, Cytotoxic Immunized T-lymphocytes which can directly destroy appropriate target cells. These cytotoxic lymphocytes may be generated in vitro in mixed lymphocyte cultures (MLC), in vivo during a graft-versus-host (GVH) reaction, or after immunization with an allograft, tumor cell or virally transformed or chemically modified target cell. The lytic phenomenon is sometimes referred to as cell-mediated lympholysis (CML). These CD8-positive cells are distinct from NATURAL KILLER CELLS and NATURAL KILLER T-CELLS. There are two effector phenotypes: TC1 and TC2. Cell-Mediated Lympholytic Cells,Cytotoxic T Cells,Cytotoxic T Lymphocyte,Cytotoxic T-Lymphocytes,TC1 Cell,TC1 Cells,TC2 Cell,TC2 Cells,Cell Mediated Lympholytic Cells,Cell, Cell-Mediated Lympholytic,Cell, TC1,Cell, TC2,Cell-Mediated Lympholytic Cell,Cytotoxic T Cell,Cytotoxic T Lymphocytes,Cytotoxic T-Lymphocyte,Lymphocyte, Cytotoxic T,Lympholytic Cell, Cell-Mediated,Lympholytic Cells, Cell-Mediated,T Cell, Cytotoxic,T Lymphocyte, Cytotoxic,T Lymphocytes, Cytotoxic,T-Lymphocyte, Cytotoxic
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured

Related Publications

T Linnemann, and C Brock, and K Sparbier, and M Muche, and A Mielke, and A Lukowsky, and W Sterry, and K Kaltoft, and K H Wiesmüller, and P Walden
Identification of melanoma-specific peptide epitopes by HLA-A2.1-restricted cytotoxic T lymphocytes.
February 2006, Acta biochimica et biophysica Sinica,
T Linnemann, and C Brock, and K Sparbier, and M Muche, and A Mielke, and A Lukowsky, and W Sterry, and K Kaltoft, and K H Wiesmüller, and P Walden
Identification of HER2/neu-derived peptide epitopes recognized by gastric cancer-specific cytotoxic T lymphocytes.
October 1998, International journal of cancer,
T Linnemann, and C Brock, and K Sparbier, and M Muche, and A Mielke, and A Lukowsky, and W Sterry, and K Kaltoft, and K H Wiesmüller, and P Walden
Identification of HLA-A33-restricted CMV pp65 epitopes as common targets for CD8(+) CMV-specific cytotoxic T lymphocytes.
March 2006, Experimental hematology,
T Linnemann, and C Brock, and K Sparbier, and M Muche, and A Mielke, and A Lukowsky, and W Sterry, and K Kaltoft, and K H Wiesmüller, and P Walden
Specific T suppressors and cytotoxic T lymphocytes recognize different epitopes on Abbm12 molecule.
January 1990, Immunogenetics,
T Linnemann, and C Brock, and K Sparbier, and M Muche, and A Mielke, and A Lukowsky, and W Sterry, and K Kaltoft, and K H Wiesmüller, and P Walden
HIV epitopes recognized by cytotoxic T-lymphocytes.
January 1991, AIDS (London, England),
T Linnemann, and C Brock, and K Sparbier, and M Muche, and A Mielke, and A Lukowsky, and W Sterry, and K Kaltoft, and K H Wiesmüller, and P Walden
Identification of antigenic epitopes recognized by Mac-2 binding protein-specific cytotoxic T lymphocytes for use in cancer immunotherapy.
May 2004, Biochemical and biophysical research communications,
T Linnemann, and C Brock, and K Sparbier, and M Muche, and A Mielke, and A Lukowsky, and W Sterry, and K Kaltoft, and K H Wiesmüller, and P Walden
HIV-specific cytotoxic T lymphocytes.
January 1989, Research in immunology,
T Linnemann, and C Brock, and K Sparbier, and M Muche, and A Mielke, and A Lukowsky, and W Sterry, and K Kaltoft, and K H Wiesmüller, and P Walden
Cytotoxic T lymphocytes specific for influenza virus.
January 1994, Current topics in microbiology and immunology,
T Linnemann, and C Brock, and K Sparbier, and M Muche, and A Mielke, and A Lukowsky, and W Sterry, and K Kaltoft, and K H Wiesmüller, and P Walden
HLA-A3 restricted mutant ras specific cytotoxic T-lymphocytes induced by vaccination with T-helper epitopes.
January 2003, Journal of molecular medicine (Berlin, Germany),
T Linnemann, and C Brock, and K Sparbier, and M Muche, and A Mielke, and A Lukowsky, and W Sterry, and K Kaltoft, and K H Wiesmüller, and P Walden
Identification of HLA-A*2402-restricted HCMV immediate early-1 (IE-1) epitopes as targets for CD8+ HCMV-specific cytotoxic T lymphocytes.
August 2009, Journal of translational medicine,
Copied contents to your clipboard!